John J. Kirby
Director/Board Member bei Delaware Museum of Natural History, Inc.
Vermögen: 15 316 $ am 31.07.2023
Profil
John J.
Kirby is a professional with experience in various firms.
He is currently a Trustee at Delaware Museum of Natural History, Inc. Kirby has previously worked as a Regional Audit Director at AstraZeneca Pharmaceuticals LP from 2010 to 2012, as Chief Accounting Officer & Vice President at Shire ViroPharma, Inc. from 2012 to 2014, as Assistant Controller at Endo Pharmaceuticals, Inc. from 2014 to 2015, and as Chief Financial & Accounting Officer at Idera Pharmaceuticals, Inc. from 2018 to 2019.
Kirby will also be working as the Chief Financial Officer at Aceragen, Inc. from 2022 to 2023.
Kirby completed his undergraduate degree from Villanova University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ACERAGEN, INC.
0,23% | 19.07.2023 | 19 050 ( 0,23% ) | 15 316 $ | 31.07.2023 |
Aktive Positionen von John J. Kirby
| Unternehmen | Position | Beginn |
|---|---|---|
Delaware Museum of Natural History, Inc.
 Delaware Museum of Natural History, Inc. Other Consumer ServicesConsumer Services Delaware Museum of Natural History, Inc. specializes for its extensive collections of seashells, birds, and bird eggs. The company was founded by John Eleuthere du Pont in 1957 and is headquartered in Wilmington, DE. | Director/Board Member | 01.01.2018 |
Ehemalige bekannte Positionen von John J. Kirby
| Unternehmen | Position | Ende |
|---|---|---|
| ACERAGEN, INC. | Director of Finance/CFO | 28.04.2023 |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Comptroller/Controller/Auditor | 01.10.2015 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Comptroller/Controller/Auditor | 01.07.2014 |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Comptroller/Controller/Auditor | 01.08.2012 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Director of Finance/CFO | - |
Ausbildung von John J. Kirby
| Villanova University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
Delaware Museum of Natural History, Inc.
Delaware Museum of Natural History, Inc. Other Consumer ServicesConsumer Services Delaware Museum of Natural History, Inc. specializes for its extensive collections of seashells, birds, and bird eggs. The company was founded by John Eleuthere du Pont in 1957 and is headquartered in Wilmington, DE. | Consumer Services |
| Aceragen, Inc. |
